24 05, 2018

Three-year Naturalistic Study On Early Use Of Long-acting Injectable Antipsychotics In First Episode Psychosis

By | 2018-05-24T17:22:35+00:00 May 24th, 2018|Articles In Press, Featured|0 Comments

By Sofia Medrano, Amal Abdel-Baki, Emmanuel Stip, and Stéphane Potvin Abstract Poor adherence to antipsychotics, which affects outcome, is frequent in first episode psy- chosis (FEP). Most randomized studies demonstrate no superiority of long-acting injectable antipsychotics (LAI-AP) over oral antipsychotics (OAP). However, participants in these stud- ies represent a minority of patients [...]

24 05, 2018

An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature

By | 2018-05-24T17:22:35+00:00 May 24th, 2018|Articles In Press, Featured|0 Comments

By Marcela Almeida and Heather Burrell-Ward To the editor, We read with great interest the article by S. Thippaiah and colleagues in a recent issue of the journal. The authors reported the interesting case of a 19-year-old woman who presented with cyclical changes in mood and behavior, alternating between depression and [...]

11 05, 2018

A Review of Clinical Literature: Stimulants, Insomnia and Psychiatric Comorbidity in Veterans

By | 2018-05-11T16:26:32+00:00 May 11th, 2018|We Know Psychiatry|0 Comments

Prescription Stimulant Use, Misuse, and Motivations Approximately 16 million US adults used prescription stimulants in the preceding year (annual average), 5 million misused prescription stimulants without use disorders, and 0.4 million had use disorders, according to a recent study. Researchers conducted a nationally representative household population study of adults aged [...]

9 05, 2018

News From the APA Convocation: Antipsychotics, Opioids, and PTSD

By | 2018-05-09T13:04:15+00:00 May 9th, 2018|Brief Bulletins from the Field, We Know Psychiatry|0 Comments

Study Shows Continued Use of Certain Antipsychotics During Pregnancy May Increase Risk of Gestational Diabetes New York, NY. Women who take certain antipsychotic medications and continue the use of these medications through pregnancy may be at increased risk for gestational diabetes, according to new research published online today by the American Journal of [...]

9 05, 2018

Efficacy of Vortioxetine in Working Patients with GAD

By | 2018-05-09T09:40:45+00:00 May 9th, 2018|Brief Bulletins from the Field, We Know Psychiatry|0 Comments

Background Vortioxetine is an approved antidepressant that has also demonstrated positive effects on anxiety symptoms in subjects with generalized anxiety disorder (GAD). This post-hoc analysis evaluates the efficacy of vortioxetine in GAD subjects who are working and/or pursuing an education. Methods In study NCT00744627, 301 GAD subjects were randomized to [...]

30 04, 2018

Latest Research on Cannabis and Cannabidiols: Autism, Stress Anxiety and Depression

By | 2018-05-11T13:53:42+00:00 April 30th, 2018|Featured, We Know Psychiatry|0 Comments

Autism Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol (CBD), a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder (ASD). The study, scheduled to launch [...]

20 04, 2018

A Case Of Hyper Sexuality Associated With Clozapine

By | 2018-05-11T15:08:12+00:00 April 20th, 2018|Articles In Press, Featured|0 Comments

By Sereen Rose Thomson, Navin Patil, Balaji Ommurugan, and Rajesh Krishna Bhandary Abstract Schizophrenia treatment needs to cover several psychological interventions and pharmacological treatment for stabilizing the disease course and decreasing relapses. Sexual side effects are a major hindrance to patients and lead to decreased adherence to therapy and reduced quality of life. Recently, [...]

20 04, 2018

Induction Of Psychosis By Cyclobenzaprine

By | 2018-05-11T15:08:12+00:00 April 20th, 2018|Articles In Press, Featured|0 Comments

By Johan Y. Cohen and Amélie Guilbault Abstract Due to the stringent regulatory environment for therapeutics, common side-effects of drugs in the general population are largely well-documented. This is however less the case with certain patient subgroups who may exhibit significant adverse responses to therapeutics that are otherwise well-tolerated. We [...]

20 04, 2018

Letter To The Editor: A Perspective On Adolescent Chronic Pain Dismissal

By | 2018-05-11T15:08:12+00:00 April 20th, 2018|Articles In Press, Featured|0 Comments

By Jacquelin Peck, MD, and Omar Viswanath, MD ABSTRACT Optimal management of chronic pain is complex and often daunting. In the pediatric and adolescent population, care-givers face additional biases in the face of youth and perceived states of health, which compounds this challenge and frequently leads to dismissal or under-treatment of [...]

20 04, 2018

Physician Who Gave Asperger Syndrome Its Name is Tied to Nazi Killing of Children

By | 2018-05-11T13:53:42+00:00 April 20th, 2018|Featured, We Know Psychiatry|0 Comments

A new study by the medical historian, Herwig Czech, has shed more light on the revelations that Hans Asperger, the Austrian pediatrician for whom a form of autism is named, had collaborated with the Nazis and actively assisted in the killing of disabled children, according to a report in The [...]